Ajanta Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | Value Researchhttps://www.valueresearchonline.com/stories/232d9b59-f917-482c-b9ed-fd1355726e83/news-announcement/
Ajanta Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
19-Sep-2022
SHARE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 19 2022 for Aayush Agrawal Trustee Aayush Agrawal Trust